ABVC BIOPHARMA, INC. (ABVC) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00091F3047
ABVC BIOPHARMA, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 296,000.00 USD |
| Operating income | -7.15 m USD |
| EBIT | -8.10 m USD |
| Net income | -7.91 m USD |
| Diluted EPS – continuing operations | -0.39 USD |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ABVC BIOPHARMA, INC.
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.
More stocks
- Adicet Bio, Inc. (ACET)
- Lite Strategy, Inc. (LITS)
- MARIMED INC. (MRMD)
- Edesa Biotech, Inc. (EDSA)
- MIND TECHNOLOGY, INC (MIND)
- Alaska Silver Corp. (WAMFF)
- Metagenomi Therapeutics, Inc. (MGX)
- Bio Essence Corp (BIOE)
- CervoMed Inc. (CRVO)
- Scientist Home Future Health Ltd (SHFH)
- SPRUCE POWER HOLDING CORP (SPRU)
- ConnectM Technology Solutions, Inc. (CNTM)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.